Literature DB >> 21951103

Melatonin suppresses acrolein-induced IL-8 production in human pulmonary fibroblasts.

Gun-Dong Kim1, Seung Eun Lee, Tae-Ho Kim, Young-Ho Jin, Yong Seek Park, Cheung-Seog Park.   

Abstract

Cigarette smoke (CS) causes harmful alterations in the lungs and airway structures and functions that characterize chronic obstructive pulmonary disease (COPD). In addition to COPD, active cigarette smoking causes other respiratory diseases and diminishes health status. Furthermore, recent studies show that, α, β-unsaturated aldehyde acrolein in CS induces the production of interleukin (IL)-8, which is known to be related to bronchitis, rhinitis, pulmonary fibrosis, and asthma. In addition, lung and pulmonary fibroblasts secrete IL-8, which has a chemotactic effect on leukocytes, and which in turn, play a critical role in lung inflammation. On the other hand, melatonin regulates circadian rhythm homeostasis in humans and has many other effects, which include antioxidant and anti-inflammatory effects, as demonstrated by the reduced expressions of iNOS, IL-1β, and IL-6 and increased glutathione (GSH) and superoxide dismutase activities. In this study, we investigated whether melatonin suppresses acrolein-induced IL-8 secretion in human pulmonary fibroblasts (HPFs). It was found that acrolein-induced IL-8 production was accompanied by increased levels of phosphorylation of Akt and extracellular signal-regulated kinases (ERK1/2) in HPFs, and that melatonin suppressed IL-8 production in HPFs. These results suggest that melatonin suppresses acrolein-induced IL-8 production via ERK1/2 and phosphatidylinositol 3-kinase (PI3K)/Akt signal inhibition in HPFs.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21951103     DOI: 10.1111/j.1600-079X.2011.00950.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  19 in total

1.  Potential impact of silymarin in combination with chlorogenic acid and/or melatonin in combating cardiomyopathy induced by carbon tetrachloride.

Authors:  Nouf M Al-Rasheed; Nawal M Al-Rasheed; L M Faddah; Azza M Mohamed; Raeesa A Mohammad; Maha Al-Amin
Journal:  Saudi J Biol Sci       Date:  2013-09-17       Impact factor: 4.219

Review 2.  Molecular mechanisms of acrolein toxicity: relevance to human disease.

Authors:  Akshata Moghe; Smita Ghare; Bryan Lamoreau; Mohammad Mohammad; Shirish Barve; Craig McClain; Swati Joshi-Barve
Journal:  Toxicol Sci       Date:  2015-02       Impact factor: 4.849

Review 3.  Melatonin as a Potential Adjuvant Treatment for COVID-19 beyond Sleep Disorders.

Authors:  Adam Wichniak; Aleksander Kania; Mariusz Siemiński; Wiesław Jerzy Cubała
Journal:  Int J Mol Sci       Date:  2021-08-11       Impact factor: 5.923

4.  Melatonin down-regulates volume-sensitive chloride channels in fibroblasts.

Authors:  Ismail Ben Soussia; Frédérique Mies; Robert Naeije; Vadim Shlyonsky
Journal:  Pflugers Arch       Date:  2012-07-27       Impact factor: 3.657

Review 5.  Geroprotectors as a novel therapeutic strategy for COPD, an accelerating aging disease.

Authors:  Kazuhiro Ito; Thomas Colley; Nicolas Mercado
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-09-21

Review 6.  Geroprotectors as a therapeutic strategy for COPD - where are we now?

Authors:  Joanna Miłkowska-Dymanowska; Adam J Białas; Joanna Makowska; Aleksandra Wardzynska; Paweł Górski; Wojciech J Piotrowski
Journal:  Clin Interv Aging       Date:  2017-10-24       Impact factor: 4.458

7.  Melatonin suppresses fibrotic responses induced by cigarette smoke via downregulation of TGF-β1.

Authors:  Na-Rae Shin; Ji-Won Park; In-Chul Lee; Je-Won Ko; Sung-Hyeuk Park; Joong-Sun Kim; Jong-Choon Kim; Kyung-Seop Ahn; In-Sik Shin
Journal:  Oncotarget       Date:  2017-10-09

Review 8.  Melatonin as a potential anticarcinogen for non-small-cell lung cancer.

Authors:  Zhiqiang Ma; Yang Yang; Chongxi Fan; Jing Han; Dongjin Wang; Shouyin Di; Wei Hu; Dong Liu; Xiaofei Li; Russel J Reiter; Xiaolong Yan
Journal:  Oncotarget       Date:  2016-07-19

Review 9.  Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19.

Authors:  Angela E Peter; B V Sandeep; B Ganga Rao; V Lakshmi Kalpana
Journal:  Front Pharmacol       Date:  2021-01-27       Impact factor: 5.810

Review 10.  Melatonin: buffering the immune system.

Authors:  Antonio Carrillo-Vico; Patricia J Lardone; Nuria Alvarez-Sánchez; Ana Rodríguez-Rodríguez; Juan M Guerrero
Journal:  Int J Mol Sci       Date:  2013-04-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.